Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Jean N, DaSilva"'
Autor:
Elise P. Legault, Paula A. B. Ribeiro, Daniil R. Petrenyov, Gergana O. Drumeva, Charles Leduc, Sharmila Khullar, Jean N. DaSilva, Alain Steve Comtois, François B. Tournoux
Publikováno v:
BMC Sports Science, Medicine and Rehabilitation, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background It is unknown whether high-intensity interval exercise (HIIE) may potentiate or attenuate the cardiotoxic effect of chemotherapy agents such as doxorubicin (DOX) when performed shortly after treatment. The study aimed to investiga
Externí odkaz:
https://doaj.org/article/aafa0069412d461c8e6133fd283a249c
Autor:
Luis Michel Alonso Martinez, Nabil Naim, Alejandro Hernandez Saiz, José-Mathieu Simard, Mehdi Boudjemeline, Daniel Juneau, Jean N. DaSilva
Publikováno v:
Molecules, Vol 28, Iss 11, p 4517 (2023)
[13N]Ammonia is one of the most commonly used Positron Emission Tomography (PET) radiotracers in humans to assess myocardial perfusion and measure myocardial blood flow. Here, we report a reliable semi-automated process to manufacture large quantitie
Externí odkaz:
https://doaj.org/article/63c82189655c4016a3af69abedc71b8b
Autor:
Silvio Aime, Mohammed Al-Qahtani, Martin Behe, Guy Bormans, Giuseppe Carlucci, Jean N. DaSilva, Clemens Decristoforo, Adriano Duatti, Philip H. Elsinga, Klaus Kopka, Xiang-Guo Li, Zhibo Liu, Robert H. Mach, Oskar Middel, Jan Passchier, Marianne Patt, Ivan Penuelas, Ana Rey, Peter J. H. Scott, Sergio Todde, Jun Toyohara, Danielle Vugts, Zhi Yang
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-19 (2021)
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results This commentary of highlights has resul
Externí odkaz:
https://doaj.org/article/dedd32d3753a4f61a5d5a18fc542f694
Autor:
Aida M. Abreu Diaz, Gergana O. Drumeva, Daniil R. Petrenyov, Jean-François Carrier, Jean N. DaSilva
Publikováno v:
ACS Omega, Vol 5, Iss 32, Pp 20353-20362 (2020)
Externí odkaz:
https://doaj.org/article/8b6e2bc6a2e947be9124899563ef21ba
Autor:
Mark H. Dornan, Daniil Petrenyov, José-Mathieu Simard, Mehdi Boudjemeline, Roxana Mititelu, Jean N. DaSilva, Anthony P. Belanger
Publikováno v:
ACS Omega, Vol 5, Iss 33, Pp 20960-20966 (2020)
Externí odkaz:
https://doaj.org/article/b15d2552aa214be09a19d0c4ba841fc7
Autor:
Mark H. Dornan, Daniil Petrenyov, José-Mathieu Simard, Antonio Aliaga, Guoming Xiong, Julien Ghislain, Barry Bedell, Vincent Poitout, Jean N. DaSilva
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 3, Iss 1, Pp 1-15 (2018)
Abstract Background The free-fatty acid receptor-1 (FFA-1) is expressed by β-cells and is a promising target for molecular imaging of functional β-cell mass. Recently, the ((3-[18F]fluoropropyl)sulfonyl)propoxy-derivative of the high-affinity FFA-1
Externí odkaz:
https://doaj.org/article/c7921ef1b9984e53b76aa893df52a43c
Autor:
Aida Mary Abreu Diaz, Zalua Rodriguez Riera, Yanick Lee, Luis Miguel Esteves, Charles‐Olivier Normandeau, Baptiste Fezas, Alejandro Hernandez Saiz, François Tournoux, Daniel Juneau, Jean N. DaSilva
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 66:73-85
Autor:
Gergana O. Drumeva, Philippe Laporte, Luis Michel Alonso Martinez, Jean-François Carrier, Aida M. Abreu Diaz, Daniil R. Petrenyov, Jean N. DaSilva
Publikováno v:
Nuclear Medicine and Biology. :41-49
Introduction Alterations in the expression of the Angiotensin II type 1 receptors (AT1R) have been demonstrated in the development of several heart and renal diseases. The aim of this study was to evaluate the novel compound [18F]fluoropyridine-cande
Autor:
Basma Ismail, Rob A deKemp, Etienne Croteau, Tayebeh Hadizad, Kevin D Burns, Rob S Beanlands, Jean N DaSilva
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177451 (2017)
ACE inhibitors are considered first line of treatment in patients with many forms of chronic kidney disease (CKD). Other antihypertensives such as calcium channel blockers achieve similar therapeutic effectiveness in attenuating hypertension-related
Externí odkaz:
https://doaj.org/article/bfea89fc32b64eaeb73247ba2fbc351c
Autor:
Gergana O. Drumeva, Jean N. DaSilva, Jean-François Carrier, Daniil R. Petrenyov, Aida M. Abreu Diaz
Publikováno v:
ACS Omega, Vol 5, Iss 32, Pp 20353-20362 (2020)
ACS Omega
ACS Omega
A novel 7-((4-(3-((2-[18F]fluoropyridin-3-yl)oxy)propyl)-1H-1,2,3-triazol-1-yl)methyl)-1H-benzo[d]imidazole derivative of the angiotensin II type-1 receptor (AT1R) blocker candesartan, [18F]fluoropyridine–candesartan, was synthesized via the copper